| ALT Stock | | | USD 8.25 0.07 0.86% |
Altimmune financial indicator trend analysis is way more than just evaluating Altimmune prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Altimmune is a good investment. Please check the relationship between Altimmune Capital Surpluse and its Common Stock accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Altimmune Stock please use our
How to Invest in Altimmune guide.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Altimmune Capital Surpluse account and
Common Stock. At this time, the significance of the direction appears to have very week relationship.
The correlation between Altimmune's Capital Surpluse and Common Stock is 0.23. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Common Stock in the same time period over historical financial statements of Altimmune, assuming nothing else is changed. The correlation between historical values of Altimmune's Capital Surpluse and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of Altimmune are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Capital Surpluse i.e., Altimmune's Capital Surpluse and Common Stock go up and down completely randomly.
Correlation Coefficient | 0.23 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Most indicators from Altimmune's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Altimmune current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Altimmune Stock please use our
How to Invest in Altimmune guide.At this time, Altimmune's
Tax Provision is comparatively stable compared to the past year.
Sales General And Administrative To Revenue is likely to gain to 44.70 in 2024, despite the fact that
Enterprise Value Over EBITDA is likely to grow to
(5.02).
When running Altimmune's price analysis, check to
measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to
predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.